01/14/2025
4:28 PM | Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics Inc. - Common Stock (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/09/2025
11:15 PM | Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics Inc. - Common Stock (Filer)
| Form EFFECT | |
01/07/2025
5:18 AM | Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics Inc. - Common Stock (Filer)
| Form S-3/A | |
12/29/2024
11:15 PM | Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics Inc. - Common Stock (Filer)
| Form EFFECT | |
12/29/2024
11:15 PM | Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics Inc. - Common Stock (Filer)
| Form EFFECT | |
12/23/2024
4:14 PM | BIONOMICS LIMITED/FI (Filer)
BIONOMICS LIMITED/FI (Filer)
Neuphoria Therapeutics Inc. - Common Stock (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/23/2024
3:56 PM | BIONOMICS LIMITED/FI (Filer)
BIONOMICS LIMITED/FI (Filer)
Neuphoria Therapeutics Inc. - Common Stock (Filer)
| Form 15-12G | |
|
12/23/2024
4:02 PM | BIONOMICS LIMITED/FI (Filer)
BIONOMICS LIMITED/FI (Filer)
Neuphoria Therapeutics Inc. - Common Stock (Filer)
| Form POS AM | |
12/23/2024
4:03 PM | BIONOMICS LIMITED/FI (Filer)
BIONOMICS LIMITED/FI (Filer)
Neuphoria Therapeutics Inc. - Common Stock (Filer)
| Form POS AM | |
12/16/2024
3:46 PM | BIONOMICS LIMITED/FI (Filer)
BIONOMICS LIMITED/FI (Filer)
Neuphoria Therapeutics Inc. - Common Stock (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/12/2024
4:02 PM | BIONOMICS LIMITED/FI (Filer)
BIONOMICS LIMITED/FI (Filer)
Neuphoria Therapeutics Inc. - Common Stock (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/21/2024
3:01 PM | BIONOMICS LIMITED/FI (Filer)
BIONOMICS LIMITED/FI (Filer)
Neuphoria Therapeutics Inc. - Common Stock (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/18/2024
3:41 PM | BIONOMICS LIMITED/FI (Filer)
BIONOMICS LIMITED/FI (Filer)
Neuphoria Therapeutics Inc. - Common Stock (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
11/14/2024
2:25 PM | ARMISTICE CAPITAL, LLC (Filed by)
BIONOMICS LIMITED/FI (Subject)
BIONOMICS LIMITED/FI (Subject)
Neuphoria Therapeutics Inc. - Common Stock (Subject)
| Form SC 13G | |
11/14/2024
8:03 AM | BIONOMICS LIMITED/FI (Subject)
BIONOMICS LIMITED/FI (Subject)
Neuphoria Therapeutics Inc. - Common Stock (Subject)
Lynx1 Capital Management LP (Filed by)
| Form SC 13G/A | |
11/13/2024
3:55 PM | BIONOMICS LIMITED/FI (Filer)
BIONOMICS LIMITED/FI (Filer)
Neuphoria Therapeutics Inc. - Common Stock (Filer)
| Form DEFA14A | |
10/10/2024
4:00 PM | BIONOMICS LIMITED/FI (Filer)
BIONOMICS LIMITED/FI (Filer)
Neuphoria Therapeutics Inc. - Common Stock (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/09/2024
7:47 AM | BIONOMICS LIMITED/FI (Filer)
BIONOMICS LIMITED/FI (Filer)
Neuphoria Therapeutics Inc. - Common Stock (Filer)
| Form PRE 14A | |
10/07/2024
5:10 PM | Apeiron Investment Group Ltd. (Filed by)
BIONOMICS LIMITED/FI (Subject)
BIONOMICS LIMITED/FI (Subject)
Neuphoria Therapeutics Inc. - Common Stock (Subject)
| Form SC 13D/A | |
09/30/2024
5:38 AM | BIONOMICS LIMITED/FI (Filer)
BIONOMICS LIMITED/FI (Filer)
Neuphoria Therapeutics Inc. - Common Stock (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
07/16/2024
5:30 AM | BIONOMICS LIMITED/FI (Filer)
BIONOMICS LIMITED/FI (Filer)
Neuphoria Therapeutics Inc. - Common Stock (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/12/2024
6:18 PM | BIONOMICS LIMITED/FI (Issuer)
BIONOMICS LIMITED/FI (Issuer)
Neuphoria Therapeutics Inc. - Common Stock (Issuer)
Davies Peter Miles Winston (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/08/2024
5:16 AM | BIONOMICS LIMITED/FI (Issuer)
BIONOMICS LIMITED/FI (Issuer)
Neuphoria Therapeutics Inc. - Common Stock (Issuer)
Cunningham Timothy M. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/08/2024
5:10 AM | BIONOMICS LIMITED/FI (Issuer)
BIONOMICS LIMITED/FI (Issuer)
Neuphoria Therapeutics Inc. - Common Stock (Issuer)
Papapetropoulos Spyros (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/08/2024
5:11 AM | BIONOMICS LIMITED/FI (Issuer)
BIONOMICS LIMITED/FI (Issuer)
Neuphoria Therapeutics Inc. - Common Stock (Issuer)
Weaver Aaron Ngoc Dung (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/08/2024
5:13 AM | BIONOMICS LIMITED/FI (Issuer)
BIONOMICS LIMITED/FI (Issuer)
Neuphoria Therapeutics Inc. - Common Stock (Issuer)
Fisher Alan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/08/2024
5:14 AM | BIONOMICS LIMITED/FI (Issuer)
BIONOMICS LIMITED/FI (Issuer)
Neuphoria Therapeutics Inc. - Common Stock (Issuer)
Wilson David Ian (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/08/2024
5:15 AM | BIONOMICS LIMITED/FI (Issuer)
BIONOMICS LIMITED/FI (Issuer)
Neuphoria Therapeutics Inc. - Common Stock (Issuer)
Ryan Jane (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/26/2024
11:15 PM | BIONOMICS LIMITED/FI (Filer)
BIONOMICS LIMITED/FI (Filer)
Neuphoria Therapeutics Inc. - Common Stock (Filer)
| Form EFFECT | |
06/26/2024
4:14 PM | BIONOMICS LIMITED/FI (Filer)
BIONOMICS LIMITED/FI (Filer)
Neuphoria Therapeutics Inc. - Common Stock (Filer)
| Form 424B3 | |
06/18/2024
6:05 AM | BIONOMICS LIMITED/FI (Filer)
BIONOMICS LIMITED/FI (Filer)
Neuphoria Therapeutics Inc. - Common Stock (Filer)
| Form F-1
Registration statement for securities of certain foreign private issuers | |
06/03/2024
4:18 PM | BIONOMICS LIMITED/FI (Filer)
BIONOMICS LIMITED/FI (Filer)
Neuphoria Therapeutics Inc. - Common Stock (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/15/2024
5:06 AM | BIONOMICS LIMITED/FI (Filer)
BIONOMICS LIMITED/FI (Filer)
Neuphoria Therapeutics Inc. - Common Stock (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/14/2024
9:20 AM | BIONOMICS LIMITED/FI (Subject)
BIONOMICS LIMITED/FI (Subject)
Neuphoria Therapeutics Inc. - Common Stock (Subject)
BIOTECHNOLOGY VALUE FUND L P (Filed by)
| Form SC 13G/A | |
02/14/2024
8:18 AM | BIONOMICS LIMITED/FI (Subject)
BIONOMICS LIMITED/FI (Subject)
Neuphoria Therapeutics Inc. - Common Stock (Subject)
Lynx1 Capital Management LP (Filed by)
| Form SC 13G/A | |
02/14/2024
5:45 AM | BIONOMICS LIMITED/FI (Subject)
BIONOMICS LIMITED/FI (Subject)
Neuphoria Therapeutics Inc. - Common Stock (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G/A | |
01/17/2024
5:03 AM | BIONOMICS LIMITED/FI (Filer)
BIONOMICS LIMITED/FI (Filer)
Neuphoria Therapeutics Inc. - Common Stock (Filer)
| Form 20-F/A | |
